Most recently, it has been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts being a scavenger https://gallagherr972egj8.iyublog.com/profile